Erratum: Identification of gene ontologies linked to prefrontals-hippocampal functional coupling in the human brain (Proceedings of the National Academy of Sciences of the United States of America (2014) 111 (9657-9662) DOI:10.1073/pnas.1404082111);Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 26, 2014, Pages 9657-9662

  Dixson, Luanna ^a   Walter, Henrik ^b   Schneider, Michael ^a   Erk, Susanne ^b   Schäfer, Axel ^a   Haddad, Leila ^a   Grimm, Oliver ^a   Mattheisen, Manuel ^c   M Nöthen, Markus ^c   Cichon, Sven ^c   H Witt, Stephanie ^d   Rietschel, Marcella ^d   Mohnke, Sebastian ^b   Seiferth, Nina ^b   Heinz, Andreas ^b   Tost, Heike ^a   Meyer Lindenberg, Andreas ^a  

^a Department of Psychiatry and Psychotherapy ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endophenotype; Functional connectivity; Genetic risk variants; GSEA

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ADULT; ARTICLE; BIOGENESIS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE IDENTIFICATION; GENE ONTOLOGY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HIPPOCAMPUS; HUMAN; MALE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROIMAGING; NORMAL HUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SYNAPSE; WHITE MATTER;

ENDOPHENOTYPE; FUNCTIONAL CONNECTIVITY; GENETIC RISK VARIANTS; GSEA;

CALCIUM CHANNELS, L-TYPE; CELL ADHESION MOLECULES; CONNECTOME; GENE ONTOLOGY; GENOTYPE; GERMANY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; PHENOTYPE; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 84903704185     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1415682111     Document Type: Erratum

References (94)

1. Meyer-Lindenberg A (2010) From maps to mechanisms through neuroimaging of schizophrenia. Nature 468(7321):194-202.
2. Meyer-Lindenberg AS, et al. (2005) Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 62(4):379-386.
3. Bilek E, et al. (2013) Application of high-frequency repetitive transcranial magnetic stimulation to the DLPFC alters human prefrontal- hippocampal functional interaction. J Neurosci 33(16):7050-7056.
4. Rasetti R, et al. (2011) Altered cortical network dynamics: A potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry 68(12):1207-1217.
5. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44(7):660-669.
6. Bertolino A, et al. (1997) Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: A proton magnetic resonance spectroscopic imaging study. Cereb Cortex 7(8):740-748.
7. Blokland GA, et al. (2011) Heritability of working memory brain activation. J Neurosci 31(30):10882-10890.
8. Wolf RC, et al. (2009) Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33(8):1464-1473.
9. Esslinger C, et al. (2009) Neural mechanisms of a genome-wide supported psychosis variant. Science 324(5927):605.
10. Esslinger C, et al. (2011) Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A. Neuroimage 54(3):2514-2523.
11. Paulus FM, et al. (2014) Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum Brain Mapp 35(4):1190-1200.
12. Crossley NA, et al. (2009) Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp 30(12):4129-4137.
13. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA (2010) Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464(7289):763-767.
14. Stephan KE, Baldeweg T, Friston KJ (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59(10):929-939.
15. Meyer-Lindenberg A (2011) Neuroimaging and the question of neurodegeneration in schizophrenia. Prog Neurobiol 95(4):514-516.
16. Erk S, et al. (2010) Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 67(8):803-811.
17. Walter H, et al. (2011) Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry 16(4):462-470.
18. Sullivan PF, Daly MJ, O'Donovan M (2012) Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet 13(8):537-551.
19. Jia P, Wang L, Meltzer HY, Zhao Z (2010) Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data. Schizophr Res 122(1-3):38-42.
20. Askland K, Read C, Moore J (2009) Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum Genet 125(1):63-79.
21. Holmans P, et al.; Wellcome Trust Case-Control Consortium (2009) Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am J Hum Genet 85(1):13-24.
22. Lips ES, et al.; International Schizophrenia Consortium (2012) Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 17(10):996-1006.
23. Mootha VK, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267-273.
24. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43): 15545-15550.
25. Wang K, Li M, Bucan M (2007) Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81(6):1278-1283.
26. Ersland KM, et al. (2012) Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders. PLoS ONE 7(2):e31687.
27. Potkin SG, et al. (2010) Identifying gene regulatory networks in schizophrenia. Neuroimage 53(3):839-847.
28. Meyer-Lindenberg A, et al. (2001) Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158(11):1809-1817.
29. Callicott JH, et al. (2003) Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160(4):709-719.
30. Seal RL, Gordon SM, Lush MJ, Wright MW, Bruford EA (2011) genenames.org: The HGNC resources in 2011. Nucleic Acids Res 39(Database Issue):D514-D519.
31. Faludi G, Mirnics K (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 29(3):305-309.
32. Seshadri S, Zeledon M, Sawa A (2013) Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol Dis 53:26-35.
33. Voineskos D, Rogasch NC, Rajji TK, Fitzgerald PB, Daskalakis ZJ (2013) A review of evidence linking disrupted neural plasticity to schizophrenia. Can J Psychiatry 58(2):86-92.
34. Goto Y, Yang CR, Otani S (2010) Functional and dysfunctional synaptic plasticity in prefrontal cortex: Roles in psychiatric disorders. Biol Psychiatry 67(3):199-207.
35. Lewis DA (2009) Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. Dialogues Clin Neurosci 11(3):269-280.
36. Wheeler AL, et al. (2014) Disrupted prefrontal interhemispheric structural coupling in schizophrenia related to working memory performance. Schizophr Bull 40(4):914-924.
37. Hasan A, et al. (2011) Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation. Behav Brain Res 224(1):15-22.
38. Rogasch NC, Daskalakis ZJ, Fitzgerald PB (2014) Cortical inhibition, excitation, and connectivity in schizophrenia: A review of insights from transcranial magnetic stimulation. Schizophr Bull 40(3):685-696.
39. Maynard TM, Sikich L, Lieberman JA, LaMantia AS (2001) Neural development, cellcell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull 27(3): 457-476.
40. Gilman SR, et al. (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70(5):898-907.
41. FromerM, et al. (2014) De novomutations in schizophrenia implicate synaptic networks. Nature 506(7487):179-184.
42. Guilmatre A, et al. (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66(9):947-956.
43. O'Dushlaine C, et al.; International Schizophrenia Consortium (2011) Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16(3):286-292.
44. Lewis CM, et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73(1):34-48.
45. Kim HJ, et al. (2009) Association between neuronal cell adhesion molecule (NRCAM) single nucleotide polymorphisms and schizophrenia in a Korean population. Psychiatry Clin Neurosci 63(1):123-124.
46. Brennaman LH, et al. (2011) Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity. Neurobiol Dis 43(2): 372-378.
47. Gilabert-Juan J, et al. (2012) Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients. Neurosci Lett 530(1):97-102.
48. PoltorakM, et al. (1996) Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem 66(4):1532-1538.
49. Sullivan PF, et al. (2007) NCAM1 and neurocognition in schizophrenia. Biol Psychiatry 61(7):902-910.
50. Pillai-Nair N, et al. (2005) Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci 25(18):4659-4671.
51. Stork O, Welzl H, Cremer H, Schachner M (1997) Increased intermale aggression and neuroendocrine response in mice deficient for the neural cell adhesion molecule (NCAM) . Eur J Neurosci 9(6):1117-1125.
52. Bukalo O, et al. (2004) Conditional ablation of the neural cell adhesion molecule reduces precision of spatial learning, long-term potentiation, and depression in the CA1 subfield of mouse hippocampus. J Neurosci 24(7):1565-1577.
53. Cremer H, et al. (1994) Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature 367(6462): 455-459.
54. Gómez-Climent MA, et al. (2011) The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is expressed in a subpopulation of mature cortical interneurons characterized by reduced structural features and connectivity. Cereb Cortex 21(5): 1028-1041.
55. Hammond MS, et al. (2006) Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamateinduced cell death. J Biol Chem 281(46):34859-34869.
56. Kochlamazashvili G, et al. (2010) Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors. J Neurosci 30(11):4171-4183.
57. Marín O (2012) Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 13(2):107-120.
58. Verma A, Moghaddam B (1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. J Neurosci 16(1):373-379.
59. Dudkin KN, Chueva IV, Arinbasarov MU, Bobkova NV (2001) [Effect of a dopamine agonist on working memory in monkeys]. Ross Fiziol Zh Im I M Sechenova 87(12): 1579-1594.
60. Xiao MF, et al. (2009) Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. J Neurosci 29(47):14752-14763.
61. Budreck EC, et al. (2013) Neuroligin-1 controls synaptic abundance of NMDA-type glutamate receptors through extracellular coupling. Proc Natl Acad Sci USA 110(2): 725-730.
62. Bang ML, Owczarek S (2013) A matter of balance: Role of neurexin and neuroligin at the synapse. Neurochem Res 38(6):1174-1189.
63. Rujescu D, et al.; GROUP Investigators (2009) Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18(5):988-996.
64. Mühleisen TW, et al. (2011) Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. Schizophr Res 127(1-3):35-40.
65. Kirov G, et al. (2009) Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35(5):851-854.
66. Sun C, et al. (2011) Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia. Hum Mol Genet 20(15): 3042-3051.
67. Peixoto RT, et al. (2012) Transsynaptic signaling by activity-dependent cleavage of neuroligin-1. Neuron 76(2):396-409.
68. Prange O, Wong TP, Gerrow K, Wang YT, El-Husseini A (2004) A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci USA 101(38):13915-13920.
69. Kehrer C, Maziashvili N, Dugladze T, Gloveli T. (2008) Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front Mol Neurosci 1:6.
70. Moosmang S, et al. (2005) Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci 25(43): 9883-9892.
71. Moskvina V, et al.; Wellcome Trust Case Control Consortium (2009) Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14(3):252-260.
72. Sklar P, et al. (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558-569.
73. Ripke S, et al.; Multicenter Genetic Studies of Schizophrenia Consortium; Psychosis Endophenotypes International Consortium; Wellcome Trust Case Control Consortium 2 (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45(10):1150-1159.
74. Zoladz PR, et al. (2012) Differential expression of molecular markers of synaptic plasticity in the hippocampus, prefrontal cortex, and amygdala in response to spatial learning, predator exposure, and stress-induced amnesia. Hippocampus 22(3): 577-589.
75. Spitzer NC (2006) Electrical activity in early neuronal development. Nature 444(7120): 707-712.
76. Bigos KL, et al. (2010) Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 67(9):939-945.
77. Altar CA, et al. (2005) Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58(2):85-96.
78. Aston C, Jiang L, Sokolov BP (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77(6):858-866.
79. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22(7): 2718-2729.
80. Bousman CA, et al. (2010) Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet 153B(2):494-502.
81. Rubio MD, Wood K, Haroutunian V, Meador-Woodruff JH (2013) Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia. Neuropsychopharmacology 38(10):1910-1920.
82. Sentissi O, Epelbaum J, Olié JP, Poirier MF (2008) Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: A review. Schizophr Bull 34(6):1189-1199.
83. Diano S, et al. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9(3):381-388.
84. Li E, et al. (2013) Ghrelin directly stimulates adult hippocampal neurogenesis: Implications for learning and memory. Endocr J 60(6):781-789.
85. Spitznagel MB, et al. (2010) Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiatry Clin Neurosci 64(6):608-611.
86. Ribeiro LF, et al. (2014) Ghrelin triggers the synaptic incorporation of AMPA receptors in the hippocampus. Proc Natl Acad Sci USA 111(1):E149-E158.
87. Friedman L, Glover GH (2006) Report on a multicenter fMRI quality assurance protocol. J Magn Reson Imaging 23(6):827-839.
88. Plichta MM, et al. (2012) Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery. Neuroimage 60(3):1746-1758.
89. Purcell S, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
90. Christoforou A, et al. (2012) Linkage-disequilibrium-based binning affects the interpretation of GWASs. Am J Hum Genet 90(4):727-733.
91. Huang H, Chanda P, Alonso A, Bader JS, Arking DE (2011) Gene-based tests of association. PLoS Genet 7(7):e1002177.
92. Saccone SF, et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16(1):36-49.
93. Ashburner M, et al.; The Gene Ontology Consortium (2000) Gene ontology: Tool for the unification of biology. Nat Genet 25(1):25-29.
94. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: A desktop application for Gene Set Enrichment Analysis. Bioinformatics 23(23):3251-3253.